Ledger.Open graph →
SEC Form D · Amendment · filed January 24, 2022

Phylos Bioscience, Inc

Offering
—
Sold
—
Exemption
Rule 506(b)
Industry
Other
Location
PORTLAND, OR
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Dylan J. Anderson · Portland, ORExecDavid J. Patterson · Portland, ORDirectorRalph J. Risch · Portland, ORExec · DirectorTimothy J. Gregory · Portland, ORDirectorMina Mishrikey · Portland, ORDirectorNishan Karassik · Portland, ORExec · DirectorJeffery Sarrett · Denver, COExecWilliam D. De Laszlo · Los Angeles, CAExec · DirectorDaniel Benel · Denver, CODirectorJeffrey Manno · Charleston, SCExec · DirectorRick Schultze · Charleston, SCExecAustin R. Fitzgerald · Idaho Falls, IDDirectorTimothy J. Gregory · Portland, ORDirectorMina Mishrikey · Portland, ORDirectorNishan Karassik · Portland, ORExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗